Time Lines of Infection and Disease in Human Influenza: A Review of Volunteer Challenge Studies
Top Cited Papers
Open Access
- 29 January 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 167 (7), 775-785
- https://doi.org/10.1093/aje/kwm375
Abstract
The dynamics of viral shedding and symptoms following influenza virus infection are key factors when considering epidemic control measures. The authors reviewed published studies describing the course of influenza virus infection in placebo-treated and untreated volunteers challenged with wild-type influenza virus. A total of 56 different studies with 1,280 healthy participants were considered. Viral shedding increased sharply between 0.5 and 1 day after challenge and consistently peaked on day 2. The duration of viral shedding averaged over 375 participants was 4.80 days (95% confidence interval: 4.31, 5.29). The frequency of symptomatic infection was 66.9% (95% confidence interval: 58.3, 74.5). Fever was observed in 37.0% of A/H1N1, 40.6% of A/H3N2 (p = 0.86), and 7.5% of B infections (p = 0.001). The total symptoms scores increased on day 1 and peaked on day 3. Systemic symptoms peaked on day 2. No such data exist for children or elderly subjects, but epidemiologic studies suggest that the natural history might differ. The present analysis confirms prior expert opinion on the duration of viral shedding or the frequency of asymptomatic influenza infection, extends prior knowledge on the dynamics of viral shedding and symptoms, and provides original results on the frequency of respiratory symptoms or fever.Keywords
This publication has 120 references indexed in Scilit:
- Can Immunity Induced by the Human Influenza Virus N1 Neuraminidase Provide Some Protection from Avian Influenza H5N1 Viruses?PLoS Medicine, 2007
- Strategies for mitigating an influenza pandemicNature, 2006
- Mitigation strategies for pandemic influenza in the United StatesProceedings of the National Academy of Sciences, 2006
- Transmissibility of 1918 pandemic influenzaNature, 2004
- Influenza-Associated Hospitalizations in the United StatesJAMA, 2004
- Factors that make an infectious disease outbreak controllableProceedings of the National Academy of Sciences, 2004
- Effect of experimental influenza A infection on systemic immune and inflammatory parameters in allergic and nonallergic adult subjectsAnnals of Allergy, Asthma & Immunology, 2001
- Abnormal middle ear pressures during experimental influenza A virus infection — role of Eustachian tube functionAuris Nasus Larynx, 2000
- Temperature-sensitive mutants of influenza A virus. Transfer of the twots-1 A 2ts lesions present in the Udorn/72-ts-1 A 2 donor virus to the influenza A/Alaska/6/77 (H 3 N 2) wild type virusArchiv für die gesamte Virusforschung, 1980
- Double-Blind Clinical Assessment of Ribavirin (Virazole) in the Prevention of Induced Infection with Type B Influenza VirusThe Journal of Infectious Diseases, 1976